GLI GLI Quality Tool
GLI Quality Tool — Version 2.0

Building a Practical TB Laboratory Proficiency Testing System

Proficiency testing (PT) gives tuberculosis laboratories an external check on whether their testing processes produce reliable results. A laboratory receives unknown specimens or case materials, tests them through its routine workflow, and submits results for comparison with an assigned value or peer performance. The exercise is valuable because it tests the complete system rather than a single instrument.

A useful PT method should cover participation, specimen handling, result submission, performance review, corrective action, and follow-up. It must fit the laboratory’s testing menu, biosafety arrangements, staffing, transport conditions, and available resources. A simple, consistently applied process is more useful than a complex procedure that staff cannot maintain.

The purpose is also broader than obtaining a passing score. PT findings can reveal training needs, transcription errors, equipment problems, weak internal quality control, or gaps in communication. Since accurate TB laboratory results influence treatment decisions and disease control, laboratories should connect PT analysis with routine quality management and patient-focused performance.

Define The Scope And Responsibilities

Begin by listing the TB services that require external assessment. These may include smear microscopy, molecular detection, rifampicin or isoniazid resistance testing, culture, identification, and drug susceptibility testing. The scope should reflect the tests the laboratory actually performs and the specimens it receives, rather than an ideal future menu.

For each testing area, identify an appropriate PT provider or an alternative external quality assessment arrangement. Confirm that the provider supplies suitable materials, clear instructions, secure result submission, performance reports, and a process for reviewing questionable outcomes. Where formal PT is unavailable, a laboratory may use rechecking, blinded rechecking, panel testing, or collaboration with a reference laboratory as an interim measure.

Responsibilities need to be written into a controlled procedure. The laboratory manager can approve participation and allocate resources, while a quality officer coordinates schedules, records, reports, and corrective actions. Testing staff should process PT materials in the same way as routine specimens, and a designated reviewer should verify submitted results before the deadline.

Establish A Controlled Participation Procedure

The procedure should describe how PT events are tracked from announcement to closure. A calendar can record the provider, test area, registration date, specimen arrival, submission deadline, responsible analyst, and date of the final report. This prevents missed rounds when staff changes or workloads increase.

PT specimens should be logged on arrival and handled according to the provider’s instructions and the laboratory’s biosafety requirements. Staff should avoid special treatment that would make the result look better than routine performance. The same instruments, reagents, worksheets, standard operating procedures, quality controls, and result authorization steps should be used whenever technically appropriate.

Documentation should preserve traceability without compromising the confidentiality of the exercise. Keep shipping records, receipt checks, raw observations, instrument printouts, worksheets, submitted results, provider feedback, and internal review notes. If the provider allows repeat testing, document the reason and distinguish the original result from any investigation repeat.

A controlled process also defines what happens when materials are damaged, delayed, insufficient, or unsuitable. Staff should record the issue promptly, notify the PT provider when required, and avoid assigning a technical failure to the laboratory when the event itself was compromised.

Analyze Performance Beyond The Score

When a PT report arrives, the quality officer and technical lead should review it together. Start by checking whether the submitted result matches the result recorded in the laboratory’s own system. A mismatch may indicate transcription or reporting failure even when the test itself was technically correct.

Next, classify the finding. Possible categories include analytical error, interpretation error, clerical error, specimen mix-up, equipment malfunction, reagent failure, contamination, inadequate training, or misunderstanding of the provider’s instructions. For molecular testing, review the complete run, including controls, invalid results, cycle thresholds where available, and any instrument flags.

Performance should be assessed over time rather than by a single round. A passing result does not erase a recurring weakness, while one poor result may require proportionate investigation rather than immediate blame. Useful indicators include participation rate, on-time submission rate, agreement with assigned results, percentage of unacceptable results, repeat-error frequency, and time taken to complete corrective action.

The link between laboratory quality and clinical care should remain visible during review. Resources explaining the quality and outcomes relationship can help staff connect analytical reliability with diagnosis, treatment selection, and public health decisions.

PT activity Evidence to retain Analysis question Follow-up
Registration and scheduling Provider details and PT calendar Was the laboratory enrolled for every relevant test? Assign an owner and confirm the next round
Specimen receipt Receipt log, condition check, and storage record Were materials received intact and processed on time? Report transport or packaging problems
Routine testing Worksheets, controls, instrument records, and raw data Did staff follow the usual method? Investigate deviations from the procedure
Result submission Authorized report and transmission record Was the correct result submitted before the deadline? Correct reporting or communication gaps
Provider report review Scored report and internal review record What type and pattern of error occurred? Open a documented corrective action
Effectiveness check Reassessment, retraining record, or later PT result Did the action prevent recurrence? Escalate unresolved or repeated problems

Investigate Errors With Root Cause Analysis

A corrective action should begin with a clear description of the failure. Record the expected result, the reported result, the test method, the staff involved, the relevant controls, and any conditions that could have affected performance. Avoid vague statements such as “staff error” because they rarely identify a fix.

Use a structured method suited to the laboratory. The five-whys approach can uncover weaknesses in training, instructions, supervision, or workflow. A fishbone diagram can organize possible causes under personnel, equipment, reagents, methods, environment, and management. For a specimen identification error, map every handoff from receipt through reporting instead of focusing only on the person who entered the final result.

Corrective action should address the cause and the risk. Examples include revising a worksheet, separating specimen identifiers, adding a second result check, replacing unstable reagents, servicing equipment, clarifying an interpretation rule, or providing observed competency assessment. If the event could affect patient specimens, the laboratory should assess whether routine results require review and notify responsible clinical or public health authorities according to its procedures.

Each action needs an owner, due date, required resources, and effectiveness measure. “Staff retrained” is incomplete unless the laboratory states what was taught and how competence will be demonstrated. Effectiveness may be shown through an observed run, review of several routine cases, a successful repeat panel, or improved results in the next PT cycle.

Integrate PT With The Quality Management System

PT should be managed as part of the laboratory’s overall quality system, not as an isolated annual activity. The four-phase GLI roadmap and its twelve Quality Systems Essentials provide a practical structure for connecting PT with organization, personnel, equipment, purchasing, process control, information management, assessment, and continual improvement. The GLI Quality Tool offers checklists and guidance that can help laboratories place PT tasks within those broader responsibilities.

Document control is especially important. The PT procedure, result-review form, corrective action form, and annual summary should have approved versions, defined retention periods, and controlled access. Obsolete forms can create avoidable errors if staff use outdated scoring rules or reporting fields.

Personnel records should show who performed the testing, who reviewed the result, and whether the person was authorized and competent for the method. Equipment and reagent records can help determine whether a failed result coincided with maintenance, calibration, lot changes, storage excursions, or control failures. Internal audits can then test whether the written PT process is actually followed.

Laboratory leadership should review PT trends during management review. The discussion can include repeated errors, resource needs, overdue actions, provider concerns, and changes to the testing menu. This turns external assessment into evidence for decisions about staffing, procurement, training, and risk reduction.

Create A Review Rhythm And Improvement Plan

A PT program benefits from a predictable review rhythm. Before each round, confirm enrollment, staff availability, equipment status, reagent stock, and submission arrangements. During the round, record events in real time. After the report arrives, complete the technical review promptly while details remain available.

An annual summary can show whether performance is stable and whether previous actions worked. Separate technical failures from administrative failures, since each requires a different response. Compare results by test method, location, instrument, and staff group when the data support that analysis, while protecting individual confidentiality.

Use the following practices to keep the system practical:

Laboratories should also communicate relevant findings without creating a culture of punishment. A transparent review encourages staff to report unclear instructions, equipment concerns, and near misses early. The objective is dependable testing, supported by learning and accountability.

Turn Findings Into Measurable Action

A strong method ends with evidence that improvement has occurred. Set targets such as 100% participation in enrolled PT rounds, on-time submission above an agreed threshold, no repeated clerical errors, or closure of corrective actions within a defined period. Targets should be realistic for the laboratory’s workload and resource setting.

Review the indicators at least annually and after any serious failure. If performance remains weak, the laboratory may need a deeper assessment of staffing, workflow, method validation, supply continuity, or supervisory capacity. Escalation should be based on risk, especially where an error could lead to missed TB, incorrect resistance classification, or inappropriate treatment.

The laboratory can share suitable feedback with its national TB program, reference laboratory, or quality network while preserving confidential information. For questions about the usefulness or usability of the GLI resource, laboratories can share feedback, helping keep the guidance relevant to varied laboratory environments.

Start by mapping the next PT round, assigning responsibilities, and preparing a simple review form. Then use the provider’s report as a source of evidence for corrective action, management review, and safer patient care. A repeatable process, supported by clear records and timely follow-up, turns proficiency testing into a lasting improvement tool rather than a pass-or-fail event.